Shenzhen New Industries Biomedical Cash Flow Conversion Efficiency

Latest as of September 2025: 0.069x

Shenzhen New Industries Biomedical cash flow conversion efficiency. Based on the latest financial reports, Shenzhen New Industries Biomedical (300832) has a cash flow conversion efficiency ratio of 0.069x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥606.21 Million ≈ $88.71 Million USD) by net assets (CN¥8.74 Billion ≈ $1.28 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shenzhen New Industries Biomedical (2012–2024)

Cash flow conversion efficiency of Shenzhen New Industries Biomedical from 2012 to 2024. This chart illustrates how Shenzhen New Industries Biomedical's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shenzhen New Industries Biomedical stock price for real-time trading data and today's change.

Shenzhen New Industries Biomedical Cash Flow Conversion Ratio Explained

Shenzhen New Industries Biomedical cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shenzhen New Industries Biomedical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenzhen New Industries Biomedical ranked by their cash flow conversion efficiency. Also see Shenzhen New Industries Biomedical market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Valley National Bancorp NASDAQ:VLY	0.025x
South Bow Corporation TO:SOBO	0.096x
Commercial Metals Company NYSE:CMC	0.038x
Hongfa Technology Co Ltd SHG:600885	0.046x
JSW Infrastructure Limited NSE:JSWINFRA	0.112x
Sunny Optical Technology (Group) Company Limited F:SXC	0.018x
UGI Corporation NYSE:UGI	0.046x
SSAB AB (publ) ST:SSAB-B	0.047x

Annual Cash Flow Conversion Efficiency for Shenzhen New Industries Biomedical (2012–2024)

The table below shows the annual cash flow conversion efficiency of Shenzhen New Industries Biomedical from 2012 to 2024. Review how much free cash does Shenzhen New Industries Biomedical generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥8.58 Billion ≈ $1.26 Billion	CN¥1.36 Billion ≈ $198.49 Million	0.158x	-15.87%
2023-12-31	CN¥7.54 Billion ≈ $1.10 Billion	CN¥1.42 Billion ≈ $207.54 Million	0.188x	+25.01%
2022-12-31	CN¥6.40 Billion ≈ $936.45 Million	CN¥962.39 Million ≈ $140.83 Million	0.150x	+9.15%
2021-12-31	CN¥5.61 Billion ≈ $821.21 Million	CN¥773.22 Million ≈ $113.15 Million	0.138x	-32.23%
2020-12-31	CN¥4.80 Billion ≈ $703.01 Million	CN¥976.65 Million ≈ $142.92 Million	0.203x	-23.28%
2019-12-31	CN¥3.14 Billion ≈ $459.30 Million	CN¥831.73 Million ≈ $121.71 Million	0.265x	-10.68%
2018-12-31	CN¥2.37 Billion ≈ $346.26 Million	CN¥701.97 Million ≈ $102.72 Million	0.297x	+0.19%
2017-12-31	CN¥1.77 Billion ≈ $259.33 Million	CN¥524.73 Million ≈ $76.78 Million	0.296x	-13.68%
2016-12-31	CN¥1.42 Billion ≈ $207.68 Million	CN¥486.81 Million ≈ $71.24 Million	0.343x	+14.71%
2015-12-31	CN¥1.02 Billion ≈ $149.72 Million	CN¥305.93 Million ≈ $44.77 Million	0.299x	-27.98%
2014-12-31	CN¥610.52 Million ≈ $89.34 Million	CN¥253.47 Million ≈ $37.09 Million	0.415x	+13.70%
2013-12-31	CN¥378.84 Million ≈ $55.44 Million	CN¥138.33 Million ≈ $20.24 Million	0.365x	+62.39%
2012-12-31	CN¥248.18 Million ≈ $36.32 Million	CN¥55.80 Million ≈ $8.17 Million	0.225x	--

About Shenzhen New Industries Biomedical

SHE:300832 China Medical Devices

Market Cap

$7.36 Billion

CN¥50.29 Billion CNY

Market Cap Rank

#2687 Global

#279 in China

Share Price

CN¥64.00

Change (1 day)

+8.36%

52-Week Range

CN¥39.45 - CN¥66.18

All Time High

CN¥98.01